ATE432921T1 - Quadratsäurederivate mit antiproliferativer wirkung - Google Patents
Quadratsäurederivate mit antiproliferativer wirkungInfo
- Publication number
- ATE432921T1 ATE432921T1 AT04030696T AT04030696T ATE432921T1 AT E432921 T1 ATE432921 T1 AT E432921T1 AT 04030696 T AT04030696 T AT 04030696T AT 04030696 T AT04030696 T AT 04030696T AT E432921 T1 ATE432921 T1 AT E432921T1
- Authority
- AT
- Austria
- Prior art keywords
- acid derivatives
- antiproliferative effect
- square acid
- derivatives
- cyclobut
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04030696A EP1674457B1 (de) | 2004-12-23 | 2004-12-23 | Quadratsäurederivate mit antiproliferativer Wirkung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE432921T1 true ATE432921T1 (de) | 2009-06-15 |
Family
ID=34927984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04030696T ATE432921T1 (de) | 2004-12-23 | 2004-12-23 | Quadratsäurederivate mit antiproliferativer wirkung |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP1674457B1 (de) |
| AT (1) | ATE432921T1 (de) |
| DE (1) | DE602004021404D1 (de) |
| ES (1) | ES2327840T3 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8450348B2 (en) | 2007-02-21 | 2013-05-28 | Forma Tm, Llc | Derivatives of squaric acid with anti-proliferative activity |
| MX2010014310A (es) * | 2008-06-24 | 2011-02-15 | Topotarget As | Derivados de acido escuarico como inhibidores de la nicotinamida. |
| US20120264755A1 (en) * | 2009-06-09 | 2012-10-18 | TopoTarget | Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase |
| WO2011121055A1 (en) * | 2010-03-31 | 2011-10-06 | Topotarget A/S | Pyridinyl derivatives comprising a cyanoguanidine or squaric acid moiety |
| PT2760821T (pt) | 2011-09-02 | 2018-01-11 | Novartis Ag | Sal de colina de um composto anti-inflamatório de ciclobutenodiona substituída |
| CN104936949A (zh) * | 2013-01-25 | 2015-09-23 | 百时美施贵宝公司 | 用于治疗丙型肝炎的squaric衍生物 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4522943A (en) * | 1981-05-18 | 1985-06-11 | Bristol-Myers Company | Chemical compounds |
| AU2222083A (en) * | 1982-12-14 | 1984-06-21 | Smith Kline & French Laboratories Limited | Pyridine derivatives |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US4710384A (en) | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
| EG18377A (en) | 1986-09-19 | 1993-04-30 | Lilly Co Eli | Process for preparing glycopeptide antibiotics |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| CA2149329C (en) | 1992-11-13 | 2008-07-15 | Darrell R. Anderson | Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| US5354763A (en) | 1993-11-17 | 1994-10-11 | American Home Products Corporation | Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| US5466712A (en) | 1994-11-04 | 1995-11-14 | American Home Products Corporation | Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones |
| BR9509699A (pt) | 1994-11-16 | 1998-06-30 | American Home Prod | Diaminociclobuteno 3-4-dionas |
| ATE355841T1 (de) | 1997-12-13 | 2007-03-15 | Bristol Myers Squibb Co | Verwendung von pyrazolo ( 3,4-b) pyridin als cyclin-abhängige kinase hemmer |
| EP1140792A1 (de) | 1998-12-14 | 2001-10-10 | American Home Products Corporation | 3,4-diamino-3-cyclobutene-1,2-dione derivate welche leukocytenadhesion verursacht von vla-4 inhibieren |
| US6420396B1 (en) | 1998-12-16 | 2002-07-16 | Beiersdorf Ag | Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| US6677360B2 (en) | 1998-12-16 | 2004-01-13 | Bayer Aktiengesellschaft | Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| KR20010086112A (ko) | 1998-12-16 | 2001-09-07 | 빌프리더 하이더 | 인테그린 길항제로서의 신규한 비페닐 및 비페닐 유사화합물 |
| US6114365A (en) | 1999-08-12 | 2000-09-05 | Pharmacia & Upjohn S.P.A. | Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| EP1156060B1 (de) | 2000-05-12 | 2007-06-27 | GPC Biotech AG | Humane Peptide/Proteine, die das Töten von Zellen, einschliesslich lymphoide Tumorzellen, herbeiführen oder bewirken |
| IT1317975B1 (it) | 2000-06-16 | 2003-07-21 | Christian Pio Pedulla | Presa multipla volante. |
| WO2002004426A1 (en) | 2000-07-07 | 2002-01-17 | Celltech R & D Limited | Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| EP1305291A1 (de) | 2000-08-02 | 2003-05-02 | Celltech R&D Limited | 3-substituierte isochinolin-1-yl-derivate |
| FR2815345B1 (fr) * | 2000-10-12 | 2002-12-13 | Servier Lab | Nouveaux derives de cyclobutene-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0028844D0 (en) | 2000-11-27 | 2001-01-10 | Celltech Chiroscience Ltd | Chemical compounds |
| EP1355875A1 (de) | 2001-02-02 | 2003-10-29 | Schering Corporation | 3,4-disubstituierte cyclobuten-1,2-dione als cxc chemokin-rezeptor-antagonisten |
| MXPA03007071A (es) | 2001-02-07 | 2004-05-24 | Abbott Lab | Aminaldionas como abridores del canal de potasio. |
| KR100952531B1 (ko) | 2001-04-16 | 2010-04-12 | 쉐링 코포레이션 | Ｃｘｃ-케모카인 수용체 리간드로서의 3,4-이치환된사이클로부텐-1,2-디온 |
| SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
-
2004
- 2004-12-23 AT AT04030696T patent/ATE432921T1/de not_active IP Right Cessation
- 2004-12-23 DE DE602004021404T patent/DE602004021404D1/de active Active
- 2004-12-23 EP EP04030696A patent/EP1674457B1/de active Active
- 2004-12-23 ES ES04030696T patent/ES2327840T3/es active Active
- 2004-12-23 EP EP09161687A patent/EP2096107A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ES2327840T3 (es) | 2009-11-04 |
| EP1674457A1 (de) | 2006-06-28 |
| DE602004021404D1 (de) | 2009-07-16 |
| EP1674457B1 (de) | 2009-06-03 |
| EP2096107A1 (de) | 2009-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE417610T1 (de) | Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen | |
| WO2006067165A3 (en) | Indolidone derivatives for the treatment or prevention of fibrotic diseases | |
| UY29633A1 (es) | Derivados de oxindol | |
| DE60303238D1 (de) | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten | |
| DE60320007D1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| BRPI0418251A (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais | |
| CY1110835T1 (el) | Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c | |
| PA8537901A1 (es) | Derivados de eteres utiles como agentes inhibidores de las isozimas pde4 | |
| ECSP056210A (es) | Preparación y uso de derivados de alquilarilo para el tratamiento de la obesidad | |
| SG149043A1 (en) | N,n-dihalogenated amino acids and derivatives | |
| TW200640445A (en) | N-halogenated amino acids, N, N-dihalogenated amino acids and derivatives; compositions and methods of using them | |
| ATE408601T1 (de) | Fredericamycin-derivate | |
| DOP2002000429A (es) | Imidazotriazinas | |
| CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
| BRPI0407662B8 (pt) | derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
| ATE432921T1 (de) | Quadratsäurederivate mit antiproliferativer wirkung | |
| BRPI0511125A (pt) | usos de ácido 5,6,7-triidroxieptanóico seus e análogos | |
| UY27451A1 (es) | 2,5-diamidoindoles sustituidos y su utilización | |
| AU2003303217A8 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
| HK1086493A1 (en) | Treatment of proliferative diseases with epothilone derivatives and radiation | |
| ATE479695T1 (de) | Sulfopyranosylacylglycerol-derivate zur anwendung in kombination mit bestrahlung in einer tumor- radiotherapie | |
| GB0229022D0 (en) | Organic Compounds | |
| HK1080768A1 (en) | Use of epothilone derivatives for the treatment ofhyperparathyroidism | |
| WO2004006900A3 (en) | Sulphydryl compounds in combination with sulphone or sulphnamide conpounds for use in microbial inflammatory diseases | |
| DOP2003000657A (es) | Amidas de acidos 2-heteroarilcarboxilicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |